NovaBridge Biosciences
(NASDAQ) IMAB
NovaBridge Biosciences Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$38.21M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
IMAB News
IMAB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout NovaBridge Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
32
CEO
Xi-Yong Fu, PhD, MBA
Website
www.i-mabbiopharma.comHeadquarters
Rockville, 200124, US
IMAB Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-11%
Return on Capital
-5%
Return on Assets
-3%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$375.36M
EBITDA
$373.45M
Operating Cash Flow
$52.67M
Capital Expenditure
$48.00K
Free Cash Flow
$52.72M
Cash & ST Invst.
$173.40M
Total Debt
$3.88M
NovaBridge Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
32
N/A
Net Income
$5.50M
-121.9%
EBITDA
$7.11M
+93.1%
Quarterly Fundamentals
Net Cash
$162.13M
-89.2%
Accounts Receivable
$2.03M
N/A
Inventory
$0.00
N/A
Long Term Debt
$2.63M
-18.4%
Short Term Debt
$853.00K
+15.7%
Return on Assets
-3.36%
N/A
Return on Invested Capital
-4.82%
N/A
Free Cash Flow
$0.00
N/A
Operating Cash Flow
$0.00
N/A